openPR Logo
Press release

Keratitis Market to Reach USD 4.8 Billion by 2034

09-23-2025 02:21 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Keratitis Market

Keratitis Market

Keratitis is an inflammation of the cornea that may result from infections (bacterial, viral, fungal, parasitic) or non-infectious causes such as contact lens misuse, trauma, or dry eye disease. Symptoms include eye pain, redness, blurred vision, tearing, photophobia, and corneal ulcers. If untreated, keratitis can cause scarring, vision impairment, or blindness, making timely diagnosis and treatment crucial.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72259

The global burden of keratitis is increasing due to rising contact lens use, ocular trauma cases, and prevalence of herpes simplex virus (HSV)-related eye infections. Advances in antimicrobial therapies, novel antifungals, antivirals, and regenerative approaches are reshaping the treatment landscape.

Market Overview
• Market Size (2024): USD 2.3 billion
• Forecast (2034): USD 4.8 billion
• CAGR (2025-2034): 7.6%

Key Highlights:
• Bacterial keratitis dominates globally, but fungal and viral keratitis are on the rise.
• Growing need for broad-spectrum and targeted antimicrobials.
• Development of next-gen antifungals, antivirals, and nanotechnology-based drug delivery.
• Rising investments in ocular surface regenerative medicine.

Segmentation Analysis
By Cause/Type:
• Bacterial Keratitis (largest share)
• Viral Keratitis (HSV, VZV)
• Fungal Keratitis
• Acanthamoeba Keratitis
• Non-Infectious Keratitis (trauma, autoimmune, dry eye-related)

By Treatment Type:
• Antibiotics
• Antifungals
• Antivirals
• Corticosteroids & Anti-Inflammatory Agents
• Corneal Transplantation / Surgical Interventions
• Emerging Therapies (stem cell, regenerative treatments)

By Route of Administration:
• Topical (eye drops - primary mode)
• Oral
• Injectable (intravitreal, subconjunctival)

By End Use:
• Hospitals & Specialty Eye Clinics
• Ambulatory Surgical Centers
• Research & Academic Institutes
• Retail & Online Pharmacies

Segmentation Summary:
Topical antimicrobials remain the mainstay of keratitis treatment, while surgical interventions and regenerative therapies are reserved for severe and refractory cases.

Explore Full Report here: https://exactitudeconsultancy.com/reports/72259/keratitis-market

Regional Analysis
North America
• Largest market (~41% share in 2024).
• High contact lens user base and increasing HSV-related keratitis cases.
• Strong availability of advanced antifungals and antivirals.
Europe
• ~30% share.
• Germany, UK, and France leading in keratitis clinical management.
• Growing research in antimicrobial resistance in ocular infections.
Asia-Pacific
• Fastest-growing region, CAGR ~8.4%.
• Higher incidence of fungal keratitis in India and Southeast Asia.
• Expanding corneal transplant programs in China and Japan.
Latin America
• Rising keratitis burden due to trauma and infections in rural areas.
• Brazil and Mexico leading in adoption of newer antifungal agents.
Middle East & Africa
• Significant unmet need with high rates of corneal blindness from keratitis.
• GCC countries expanding advanced ophthalmology care.
Regional Summary:
North America and Europe lead in innovation and treatment access, while Asia-Pacific faces the highest disease burden and fastest growth potential.

Market Dynamics
Key Growth Drivers:
• Rising global contact lens usage.
• Increasing ocular trauma cases in developing nations.
• Higher incidence of viral and fungal eye infections.
• Growth of ocular regenerative and transplantation therapies.

Key Challenges:
• Rising antimicrobial resistance in bacterial keratitis.
• Limited treatment options for fungal and parasitic keratitis.
• High costs and risks associated with corneal transplantation.
• Lack of access to timely care in low-income regions.

Latest Trends:
• Development of nanoparticle-based ocular drug delivery for improved penetration.
• Research into broad-spectrum antifungal and antiviral agents.
• Growing interest in stem cell therapy for corneal regeneration.
• Use of AI-driven diagnostic platforms for faster keratitis detection.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72259

Competitor Analysis
Major Players in the Market:
• Novartis AG (Sandoz - anti-infective portfolio)
• Bausch + Lomb
• Santen Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Allergan (AbbVie Inc.)
• Alcon Inc.
• Aerie Pharmaceuticals, Inc.
• Regeneron Pharmaceuticals, Inc.
• Sun Pharmaceutical Industries Ltd.
• Glenmark Pharmaceuticals

Competitive Summary:
Novartis, Bausch, and Alcon dominate antimicrobials and ocular anti-inflammatories. Santen and Sun Pharma focus on Asia-Pacific markets. Biotech companies are driving innovation in novel antifungals, antivirals, and regenerative corneal therapies.

Conclusion
The Keratitis Market, valued at USD 2.3 billion in 2024, is projected to reach USD 4.8 billion by 2034, growing at a CAGR of 7.6%.

Key Takeaways:
• Bacterial keratitis dominates, but fungal and viral types are increasing.
• Topical antimicrobials remain central, but regenerative and transplant therapies are gaining ground.
• North America and Europe lead adoption, while Asia-Pacific carries the largest disease burden.
• Innovation in nanotechnology-based drug delivery and stem cell therapy will define the future.

Over the next decade, keratitis management will expand beyond conventional antimicrobials to include advanced regenerative and precision-based solutions, improving outcomes and reducing global corneal blindness.

This report is also available in the following languages : Japanese (角膜炎市場), Korean (각막염 시장), Chinese (角膜炎市场), French (Marché de la kératite), German (Keratitis-Markt), and Italian (Mercato della cheratite), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72259/keratitis-market#request-a-sample

Our More Reports:

Graft versus Host Disease (GvHD) Market
https://exactitudeconsultancy.com/reports/72886/graft-versus-host-disease-gvhd-market

Non-Viral Drug Delivery Systems Market
https://exactitudeconsultancy.com/reports/72887/non-viral-drug-delivery-systems-market

Immunocytokines Market
https://exactitudeconsultancy.com/reports/72888/immunocytokines-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Keratitis Market to Reach USD 4.8 Billion by 2034 here

News-ID: 4194299 • Views:

More Releases from Exactitude Consultancy

Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitation and Infrastructure Projects
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250 Key Market Highlights • Increasing focus on road maintenance and resurfacing projects • Growing demand for efficient and precision milling
Credit Management Software Market Accelerates as Organizations Focus on Risk Mitigation and Cash Flow Optimization
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248 Key Market Highlights • Growing adoption of automated credit risk assessment tools • Increasing focus on working capital and cash flow management • Integration
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Operators Strengthen Network Security
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246 Key Market Highlights • Growing adoption of VoIP and
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Traction Amid Global Decarbonization Efforts
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244 Key Market Highlights • Rapid growth of

All 5 Releases


More Releases for Keratitis

Acanthamoeba Keratitis Market Dynamics Indicate Upward Trajectory Through 2034, …
The Acanthamoeba Keratitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acanthamoeba Keratitis pipeline products will significantly revolutionize the Acanthamoeba Keratitis market dynamics. DelveInsight's "Acanthamoeba Keratitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Acanthamoeba Keratitis, historical and forecasted epidemiology as well as the Acanthamoeba Keratitis market trends in the United
Herpes Simplex Keratitis Drug Market: Accelerating Innovations to Safeguard Visi …
Herpes simplex keratitis (HSK)-a viral infection of the cornea caused predominantly by herpes simplex virus type 1-remains a leading cause of corneal blindness worldwide. Characterized by painful corneal ulcers, recurrent flare ups, and potential vision loss, HSK places a significant burden on patients, healthcare systems, and societies at large. With an estimated 500,000 new cases of ocular herpes annually in developed markets alone, pharmaceutical and biotech companies are intensifying efforts
Key Neurotrophic Keratitis Treatment Market Trend for 2025-2034: Innovative Drug …
What Is the Future Outlook for the Neurotrophic Keratitis Treatment Market's Size and Growth Rate? The neurotrophic keratitis treatment market has experienced robust growth in recent years. It is forecasted to grow from $5.1 billion in 2024 to $5.51 billion in 2025, at a CAGR of 8.1%. Historical growth has been influenced by increased diagnoses, a rising number of injuries and surgical procedures, ongoing research and development efforts, and improvements in
Advances in Neurotrophic Keratitis Treatment: Breakthroughs and Innovations
Neurotrophic keratitis is a rare and neurodegenerative disease that affects the cornea of an eye. This disease leads to reduction or loss of cornea sensitivity. It further leads to ulcer formation and ultimately corneal perforation. Increase in special designation from the regulatory authorities is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure and upsurge in the demand for novel therapies and treatment
Fungal Keratitis Treatment Market Is Booming Worldwide with Novo, Pfizer, Viatri …
The "Global Fungal Keratitis Treatment" intelligence report, just published by USD Analytics, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Global Fungal Keratitis Treatment provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures
Neurotrophic Keratitis Market Growth Set to Surge Significantly during 2019 - 20 …
Neurotrophic Keratitis Market: Introduction Transparency Market Research has published a new report titled, "Global Neurotrophic Keratitis Market". According to the report, the global neurotrophic keratitis market was valued at US$ 91.6 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. Rise in reported cases of keratitis, increase in research & developmental activities, surge in awareness, and rise in co-morbidities & risk factors boost